• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subretinal Tissue Plasminogen Activator, Bevacizumab and Partial Gas Tamponade for 4-Week-old Submacular Hemorrhage in Retinal Arterial Macroaneurysm.

作者信息

Choe Sooyeon, Oh Baek Lok

机构信息

Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Korean J Ophthalmol. 2020 Jun;34(3):259-261. doi: 10.3341/kjo.2019.0134.

DOI:10.3341/kjo.2019.0134
PMID:32495537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7269742/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df9e/7269742/2d378d7b5741/kjo-34-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df9e/7269742/2d378d7b5741/kjo-34-259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df9e/7269742/2d378d7b5741/kjo-34-259-g001.jpg

相似文献

1
Subretinal Tissue Plasminogen Activator, Bevacizumab and Partial Gas Tamponade for 4-Week-old Submacular Hemorrhage in Retinal Arterial Macroaneurysm.视网膜下组织型纤溶酶原激活剂、贝伐单抗及部分气体填充治疗视网膜动脉大动脉瘤4周龄黄斑下出血
Korean J Ophthalmol. 2020 Jun;34(3):259-261. doi: 10.3341/kjo.2019.0134.
2
Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.视网膜下注射重组组织型纤溶酶原激活剂治疗与视网膜动脉大动脉瘤破裂相关的黄斑下出血。
Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1663-9. doi: 10.1007/s00417-014-2861-6. Epub 2014 Nov 25.
3
The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.色素上皮脱离在接受玻璃体切除术以及视网膜下联合应用rtPA和抗VEGF治疗的伴有黄斑下出血的年龄相关性黄斑变性中的作用
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1115-1123. doi: 10.1007/s00417-017-3620-2. Epub 2017 Mar 9.
4
Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.黄斑下出血的气体置换联合视网膜下空气及组织型纤溶酶原激活剂：美国的初步经验
Ophthalmol Retina. 2018 Mar;2(3):180-186. doi: 10.1016/j.oret.2017.07.012. Epub 2017 Sep 28.
5
ADVERSE EFFECT OF MACULAR INTRARETINAL HEMORRHAGE ON THE PROGNOSIS OF SUBMACULAR HEMORRHAGE DUE TO RETINAL ARTERIAL MACROANEURYSM RUPTURE.黄斑视网膜内出血对视网膜动脉大动脉瘤破裂所致黄斑下出血预后的不良影响。
Retina. 2020 May;40(5):989-997. doi: 10.1097/IAE.0000000000002460.
6
Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.应用组织型纤溶酶原激活物(subretinal tissue plasminogen activator, srt-PA)和空气动力学移位(subretinal tissue plasminogen activator, srt-PA)治疗年龄相关性黄斑变性的厚型脉络膜下出血的管理。
Am J Ophthalmol. 2014 Jun;157(6):1250-7. doi: 10.1016/j.ajo.2014.02.007. Epub 2014 Feb 13.
7
Displacement of Submacular Hemorrhage With Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade in the Setting of Myopic Degeneration.在近视性变性情况下，通过视网膜下注射重组组织型纤溶酶原激活剂和气液填充治疗黄斑下出血的移位
Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):257-259. doi: 10.3928/23258160-20190401-11.
8
VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes.玻璃体切割术联合视网膜下组织纤维蛋白溶酶原激活剂和气体填充治疗黄斑下出血：预后因素和临床结果。
Retina. 2019 Jan;39(1):172-179. doi: 10.1097/IAE.0000000000001931.
9
Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.玻璃体切除术、视网膜下注射组织型纤溶酶原激活剂及玻璃体内空气填塞治疗一名13岁男孩创伤性黄斑下出血成功移位：病例报告
BMC Ophthalmol. 2015 Aug 7;15:94. doi: 10.1186/s12886-015-0090-3.
10
Subretinal pneumatic displacement of subretinal hemorrhage.视网膜下气体移位对视网膜下出血的影响。
JAMA Ophthalmol. 2013 Dec;131(12):1632-5. doi: 10.1001/jamaophthalmol.2013.5464.

本文引用的文献

1
Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.视网膜下注射重组组织型纤溶酶原激活剂治疗与视网膜动脉大动脉瘤破裂相关的黄斑下出血。
Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1663-9. doi: 10.1007/s00417-014-2861-6. Epub 2014 Nov 25.
2
Treatment of multilevel macular hemorrhage secondary to retinal arterial macroaneurysm with submacular tissue plasminogen activator.用黄斑下组织纤溶酶原激活剂治疗视网膜动脉大动脉瘤继发的多层面黄斑出血。
Eur J Ophthalmol. 2012 Nov-Dec;22(6):1026-31. doi: 10.5301/ejo.5000140. Epub 2012 Mar 20.
3
Long-term follow-up of intravitreal bevacizumab in retinal arterial macroaneurysm: a case report.
玻璃体内注射贝伐单抗治疗视网膜动脉大动脉瘤的长期随访：病例报告
Case Rep Ophthalmol. 2011 Sep;2(3):387-91. doi: 10.1159/000334788. Epub 2011 Dec 13.
4
Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.玻璃体内注射组织型纤溶酶原激活剂与视网膜动脉大动脉瘤继发黄斑下出血的气体置换术
J Ocul Pharmacol Ther. 2005 Feb;21(1):62-7. doi: 10.1089/jop.2005.21.62.
5
Retinal arterial macroaneurysms.视网膜动脉大动脉瘤
Surv Ophthalmol. 1988 Sep-Oct;33(2):73-96. doi: 10.1016/0039-6257(88)90160-9.